Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov:103:101303.
doi: 10.1016/j.preteyeres.2024.101303. Epub 2024 Sep 19.

The relationship between intraocular pressure and glaucoma: An evolving concept

Affiliations
Review

The relationship between intraocular pressure and glaucoma: An evolving concept

Sanjay G Asrani et al. Prog Retin Eye Res. 2024 Nov.

Abstract

Intraocular pressure (IOP) is the most important modifiable risk factor for glaucoma and fluctuates considerably within patients over short and long time periods. Our field's understanding of IOP has evolved considerably in recent years, driven by tonometric technologies with increasing accuracy, reproducibility, and temporal resolution that have refined our knowledge regarding the relationship between IOP and glaucoma risk and pathogenesis. The goal of this article is to review the published literature pertinent to the following points: 1) the factors that determine IOP in physiologic and pathologic states; 2) technologies for measuring IOP; 3) scientific and clinical rationale for measuring diverse IOP metrics in patients with glaucoma; 4) the impact and shortcomings of current standard-of-care IOP monitoring approaches; 5) recommendations for approaches to IOP monitoring that could improve patient outcomes; and 6) research questions that must be answered to improve our understanding of how IOP contributes to disease progression. Retrospective and prospective data, including that from landmark clinical trials, document greater IOP fluctuations in glaucomatous than healthy eyes, tendencies for maximal daily IOP to occur outside of office hours, and, in addition to mean and maximal IOP, an association between IOP fluctuation and glaucoma progression that is independent of mean in-office IOP. Ambulatory IOP monitoring, measuring IOP outside of office hours and at different times of day and night, provides clinicians with discrete data that could improve patient outcomes. Eye care clinicians treating glaucoma based on isolated in-office IOP measurements may make treatment decisions without fully capturing the entire IOP profile of an individual. Data linking home blood pressure monitors and home glucose sensors to dramatically improved outcomes for patients with systemic hypertension and diabetes and will be reviewed as they pertain to the question of whether ambulatory tonometry is positioned to do the same for glaucoma management. Prospective randomized controlled studies are warranted to determine whether remote tonometry-based glaucoma management might reduce vision loss and improve patient outcomes.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Thomas V Johnson reports financial support was provided by National Eye Institute. Thomas V Johnson reports financial support was provided by Research to Prevent Blindness. Barbara Wirostko reports financial support was provided by Research to Prevent Blindness. Thomas V. Johnson reports equipment, drugs, or supplies was provided by ICARE. Sanjay G. Asrani reports equipment, drugs, or supplies was provided by ICARE. Sanjay G. Asrani, Lama A. Al-Aswad, Craig J. Chaya, Shan Lin, David C. Musch, Ian Pitha, Alan L. Robin, Barbara Wirostko, and Thomas V. Johnson reports a relationship with lighthouse Strategy Consulting that includes: consulting or advisory and travel reimbursement. Barbara Wirosko reports a relationship with MyEyes.com that includes: board membership, employment, and equity or stocks. The Max IOP Consensus Meeting was held in New Orleans, LA on April 22nd, 2023, and chaired by BW and TVJ. The meeting was organized by Lighthouse Strategy Consulting, which was contracted by iCare USA. SGA, BW, LAA, SL, DCM, IP, AR, and TVJ received effort and travel payments from Lighthouse Strategy Consulting for participation in the meeting. Subsequently, the authors drafted the entirety of this manuscript without input, support, or review from either Lighthouse Strategy Consulting or iCare USA. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1.
Figure 1.. Blood supply to the anterior optic nerve, optic nerve head, and retina.
Inset demonstrates changes relevant to glaucoma, including excavation of the optic nerve head, posterior bowing of the lamina cribrosa, and impaired autoregulation leading to reduced blood flow.
Figure 2.
Figure 2.. Aqueous humor dynamics.
Inset demonstrates high magnification view of the anterior chamber angle structures, as well as flow of aqueous humor (arrows) with drainage through the conventional (trabecular) and uveoscleral outflow pathways.
Figure 3.
Figure 3.. Shiotz tonometry.
A) Tonometer in case with collection of weights, aside a conversion table. B) Shiotz tonometer applied to a patient’s eye.
Figure 4.
Figure 4.. Goldmann applanation tonometry.
A) Patient positioned at slit lamp. B) Applanation of the cornea by tonometer. C) When the reading on the tonometer dial = IOP, the inner edges of the fluorescent arcs align. Separation indications dial (D) is underreading IOP and overlap indicates dial is overreading IOP.
Figure 5.
Figure 5.. Perkins applanation tonometry.
A) The Perkins tonometer is a handheld applanating device. B) Use of Perkins tonometry in a supine patient.
Figure 6.
Figure 6.. Tono-Pen.
Figure 7.
Figure 7.. iCare rebound tonometry.
Figure 8.
Figure 8.. iCare HOME2 self-tonometry.
Figure 9.
Figure 9.. Pneumotonometry.
A) The pneumotonometer base is connected by tubing to the probe. B) Use of pneumotonometry on a patient. C) Results printout which demonstrates IOP over several seconds.
Figure 10.
Figure 10.. Ocular response analyzer.
Figure 11.
Figure 11.. Precision vs accuracy in IOP measurement.
A) Precise measurements are highly reproducible, while accurate measurements overall estimate the true mean with high fidelity. B) Tonometry that is precise but not accurate may not ascertain the true intraocular hydrostatic pressure, but will clearly demonstrate patterns of relative change. C) Tonometry that is accurate but not precise can inform relative change, but only when a sufficient number of measurements of averaged.
Figure 12.
Figure 12.. IOP variability vs fluctuation
Figure 13.
Figure 13.. Metrics describing IOP fluctuation.
Hypothetical IOP measurements from a patient over 4 days. Daily maximum IOP (red; note outlier measuremen in Day 1); Daily minimum IOP (yellow; note outlier measurement in Day 3). Calculation of the mean daily IOP maximum, minimum, and range protects against outliers (which may be spurious).

References

    1. Iyer JV, Boland MV, Jefferys J, Quigley H. Defining glaucomatous optic neuropathy using objective criteria from structural and functional testing. Br J Ophthalmol. Jun 2021;105(6):789–793. doi: 10.1136/bjophthalmol-2020-316237 - DOI - PubMed
    1. Casson RJ, Chidlow G, Wood JP, Crowston JG, Goldberg I. Definition of glaucoma: clinical and experimental concepts. Clin Exp Ophthalmol. May-Jun 2012;40(4):341–9. doi: 10.1111/j.1442-9071.2012.02773.x - DOI - PubMed
    1. Friedman DS, Wolfs RCW, O'Colmain B, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol-Chic. Apr 2004;122(4):532–538. - PMC - PubMed
    1. Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophth Vis Sci. Jan 1997;38(1):83–91. - PubMed
    1. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040 A Systematic Review and Meta-Analysis. Ophthalmology. Nov 2014;121(11):2081–2090. doi: 10.1016/j.ophtha.2014.05.013 - DOI - PubMed